AIM
Aigen Investment Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6M | Buy |
32,333
+29,662
| +1,111% | +$5.51M | 0.82% | 5 |
|
|
2025
Q1 | $560K | Buy |
+2,671
| New | +$560K | 0.09% | 325 |
|
|
2024
Q4 | – | Sell |
-6,132
| Closed | -$1.21M | – | 698 |
|
|
2024
Q3 | $1.21M | Buy |
+6,132
| New | +$1.21M | 0.24% | 117 |
|
|
2024
Q2 | – | Sell |
-13,044
| Closed | -$2.38M | – | 736 |
|
|
2024
Q1 | $2.38M | Buy |
13,044
+7,055
| +118% | +$1.28M | 0.52% | 30 |
|
|
2023
Q4 | $928K | Sell |
5,989
-627
| -9% | -$97.2K | 0.17% | 166 |
|
|
2023
Q3 | $986K | Buy |
+6,616
| New | +$986K | 0.19% | 164 |
|
|
2023
Q1 | – | Sell |
-1,281
| Closed | -$207K | – | 594 |
|
|
2022
Q4 | $207K | Sell |
1,281
-17,293
| -93% | -$2.79M | 0.03% | 453 |
|
|
2022
Q3 | $2.49M | Buy |
+18,574
| New | +$2.49M | 0.36% | 78 |
|
|
2022
Q1 | – | Sell |
-105,880
| Closed | -$13.7M | – | 507 |
|
|
2021
Q4 | $13.7M | Buy |
+105,880
| New | +$13.7M | 0.84% | 5 |
|
|
2021
Q3 | – | Sell |
-15,172
| Closed | -$1.71M | – | 451 |
|
|
2021
Q2 | $1.71M | Buy |
+15,172
| New | +$1.71M | 0.3% | 91 |
|
|
2020
Q4 | – | Sell |
-74,748
| Closed | -$6.55M | – | 744 |
|
|
2020
Q3 | $6.55M | Sell |
74,748
-13,674
| -15% | -$1.2M | 0.84% | 6 |
|
|
2020
Q2 | $8.68M | Buy |
88,422
+36,882
| +72% | +$3.62M | 1.11% | 1 |
|
|
2020
Q1 | $3.93M | Buy |
+51,540
| New | +$3.93M | 0.52% | 21 |
|